Medroxyprogesterone Acetate was first introduced by Pfizer Inc in its drug Provera on Approved Prior to Jan 1, 1982. Other drugs containing Medroxyprogesterone Acetate are Depo-Subq Provera 104, Depo-Provera. 17 different companies have introduced drugs containing Medroxyprogesterone Acetate.

Medroxyprogesterone Acetate Patents

Given below is the list of patents protecting Medroxyprogesterone Acetate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Depo-subq Provera 104	US6495534	Stabilized aqueous suspensions for parenteral use	May 15, 2020 (Expired)	Pfizer

Add above patents to watchlist

Medroxyprogesterone Acetate's Family Patents

Full family tree

Medroxyprogesterone Acetate Generic API Manufacturers

Several generic applications have been filed for Medroxyprogesterone Acetate. The first generic version for Medroxyprogesterone Acetate was by Solvay Pharmaceuticals and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Amneal Eu Ltd and was approved on Jun 7, 2023.

Given below is the list of companies who have filed for Medroxyprogesterone Acetate generic, along with the locations of their manufacturing plants worldwide.